EASL Logo Access
Protected by US Patents
Session highlight of the Revolutionizing the management of HCV in high risk populations - linkage to care through point-of-care molecular testing
ILC Online Library, Session Speakers, 183506
HCV molecular point-of-care testing in high risk populations: experience in a prison setting
ILC Online Library, Celia Aitken, 173883
Advancing the goalpost: HCV RNA detection in finger prick blood for point of care applications
ILC Online Library, Anna-Maria Geretti, 173882
Enhancing testing for hepatitis C virus infection through simplified point-of-care diagnostics
ILC Online Library, Jason Grebely, 173881
Case finding, diagnosis, referral and elimination strategies for viral hepatitis
ILC Online Library, Geoffrey Dusheiko, 173880
Session highlight of the ILC 2016 GENFIT Symposium « NASH: Optimizing therapy
 for progressive disease »
ILC Online Library, Session Speakers, 132308
Discussion and Q&A
ILC Online Library, Session Speakers, 131375
Targeting different stages of disease: Hepatic and metabolic management of NASH patients
ILC Online Library, Sven Francque, 131374
NAFLD: Who are the patients in need of therapy and when do we need drugs?
ILC Online Library, Stephen Harrison, 131373
Case study: A 47 year-old woman with insidious progression of NASH
ILC Online Library, Vlad Ratziu, 131372
Introduction
ILC Online Library, Vlad Ratziu, 131371
Q&A and panel discussion
ILC Online Library, Session Speakers, 130968
Case study 2: The patient perspective
ILC Online Library, Jasmohan Bajaj, 130967
Case study 1: Individualising quality care – a case-based discussion
ILC Online Library, Debbie L Shawcross, 130966
Q&A and panel discussion
ILC Online Library, Session Speakers, 130965
Translating the pathophysiology of HE into clinical practice
ILC Online Library, Kevin Mullen, 130964
A unifying hypothesis: How do bacterial translocation, ammonia and inflammation contribute to hepatic encephalopathy?
ILC Online Library, Rajiv Jalan, 130963
Welcome and overview of agenda
ILC Online Library, Jasmohan Bajaj, 130962
Dimension 3: Managing patients who do not respond to TACE
ILC Online Library, Peter R. Galle, 99450
Q&A and closing remarks
ILC Online Library, Session Speakers, 99451
Dimension 2: Managing patients who partially respond to TACE
ILC Online Library, Jordi Bruix, 99449
Welcome and introduction
ILC Online Library, Jordi Bruix, 99447
Dimension 1: Managing patients who are not suitable for TACE
ILC Online Library, Luigi Bolondi, 99448
Panel discussion
ILC Online Library, Session Speakers, 99445
From trials to clinical practice: do IFN-free regimens keep their promises?
ILC Online Library, Fred Poordad, 99443
Audience discussion and Closing remarks
ILC Online Library, Session Speakers, 99437
GT-1b, cirrhotic (Child-Pugh B)
ILC Online Library, Rafael Esteban-Mur, 99461
GT-3 pre- and post-transplant
ILC Online Library, Kosh Agarwal, 99460
GT-1a, HCV/HIV coinfection
ILC Online Library, Jürgen Rockstroh, 99459
Using IFN-free regimens in practice: navigating through an ocean of treatment options
ILC Online Library, Tariq-Yacine ASSELAH, 99442
The new landscape of HCV treatment: is a sustained cure for all patients living with HCV achievable?
ILC Online Library, Heiner Wedemeyer, 99435
Reaching a cure today: the value of triple therapy
ILC Online Library, Maria Buti, 99441
Welcome and introduction
ILC Online Library, Heiner Wedemeyer, 99434
Introduction
ILC Online Library, Stefan Zeuzem, 99439
Symposium Highlight
ILC Online Library, Session Speakers, 105564